Glucose-based peritoneal dialysis fluids downregulate toll-like receptors and trigger hyporesponsiveness to pathogen-associated molecular patterns in human peritoneal mesothelial cells

Clinical and Vaccine Immunology

Volumn 17, Issue 5, 2010, Pages 757-763

  Wu, Jun ^a   Yang, Xiao ^a   Zhang, Yun Fang ^a   Wang, Ya Ning ^a   Liu, Mei ^a   Dong, Xiu Qing ^a   Fan, Jin Jin ^a   Yu, Xue Qing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIALYSIS FLUID; GLUCOSE; ICODEXTRIN; INTERLEUKIN 1BETA; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MESOTHELIUM CELL; PERITONEAL DIALYSIS; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; CHROMOGENIC COMPOUNDS; CYTOKINES; DIALYSIS SOLUTIONS; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GLUCANS; GLUCOSE; HUMANS; PERITONEAL DIALYSIS; PERITONEUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TETRAZOLIUM SALTS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 77951998997     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00453-09     Document Type: Article

References (31)

1. Barton, G. M., and R. Medzhitov. 2003. Toll-like receptor signaling pathways. Science 300:1524-1525.
2. Dasu, M. R., S. Devaraj, and I. Jialal. 2007. High glucose induces IL-1beta expression in human monocytes: mechanistic insights. Am. J. Physiol. Endocrinol. Metab. 293:E337-E346.
3. Dasu, M. R., S. Devaraj, L. Zhao, D. H. Hwang, and I. Jialal. 2008. High glucose induces Toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 57:3090-3098.
4. Devaraj, S., S. K. Venugopal, U. Singh, and I. Jialal. 2005. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}. Diabetes 54:85-91.
5. Edfeldt, K., J. Swedenborg, G. K. Hansson, and Z. Q. Yan. 2002. Expression of Toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105:1158-1161. (Pubitemid 34225814)
6. Gokal, R. 2002. Peritoneal dialysis in the 21st century: an analysis of current problems and future developments. J. Am. Soc. Nephrol. 13(Suppl. 1):S104-S116.
7. Ito, T., N. Yorioka, Y. Kyuden, Y. Asakimori, K. Kiribayashi, T. Ogawa, and N. Kohno. 2003. Effect of glucose polymer on the intercellular junctions of cultured human peritoneal mesothelial cells. Nephron Clin. Pract. 93:c97-c105.
8. Kato, S., Y. Yuzawa, N. Tsuboi, S. Maruyama, Y. Morita, T. Matsuguchi, and S. Matsuo. 2004. Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of Toll-like receptor 4. J. Am. Soc. Nephrol. 15:1289-1299.
9. Kazancioglu, R. 2009. Peritoneal defense mechanisms - the effects of new peritoneal dialysis solutions. Perit. Dial. Int. 29(Suppl. 2):S198-S201.
10. Krediet, R. T. 2007. 30 years of peritoneal dialysis development: the past and the future. Perit. Dial. Int. 27(Suppl. 2):S35-S41.
11. Lien, E., T. K. Means, H. Heine, A. Yoshimura, S. Kusumoto, K. Fukase, M. J. Fenton, M. Oikawa, N. Qureshi, B. Monks, R. W. Finberg, R. R. Ingalls, and D. T. Golenbock. 2000. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105:497-504.
12. Masahira, K., I. Takafumi, M. Takao, K. Nobuoki, and Y. Noriaki. 2007. Glucose-based PD solution, but not icodextrin-based PD solution, induces plasminogen activator inhibitor-1 and tissue-type plasminogen activator in human peritoneal mesothelial cells via ERK1/2. Ther. Apher. Dial. 11:94-100.
13. Methe, H., J. O. Kim, S. Kofler, M. Nabauer, and M. Weis. 2005. Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes. Arterioscler. Thromb. Vasc. Biol. 25:1439-1445.
14. Mortier, S., N. H. Lameire, and A. S. De Vriese. 2004. The effects of peritoneal dialysis solutions on peritoneal host defense. Perit. Dial. Int. 24:123-138.
15. Opitz, B., N. W. Schroder, I. Spreitzer, K. S. Michelsen, C. J. Kirschning, W. Hallatschek, U. Zahringer, T. Hartung, U. B. Gobel, and R. R. Schumann. 2001. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-kappaB translocation. J. Biol. Chem. 276:22041-22047.
16. Pecoits-Filho, R., S. Mujais, and B. Lindholm. 2002. Future of icodextrin as an osmotic agent in peritoneal dialysis. Kidney Int. 2002(Suppl.):S80-S87.
17. Posthuma, N., P. ter Wee, A. J. Donker, H. A. Dekker, P. L. Oe, and H. A. Verbrugh. 1999. Peritoneal defense using icodextrin or glucose for daytime dwell in CCPD patients. Perit. Dial. Int. 19:334-342.
18. Rougier, J. P., S. Guia, J. Hagege, G. Nguyen, and P. M. Ronco. 1998. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1. Kidney Int. 54:87-98.
19. Rougier, J. P., P. Moullier, R. Piedagnel, and P. M. Ronco. 1997. Hyperosmolality suppresses but TGF beta 1 increases MMP9 in human peritoneal mesothelial cells. Kidney Int. 51:337-347.
20. Sadeghi, K., B. Wessner, U. Laggner, M. Ploder, D. Tamandl, J. Friedl, U. Zugel, A. Steinmeyer, A. Pollak, E. Roth, G. Boltz-Nitulescu, and A. Spittler. 2006. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur. J. Immunol. 36:361-370.
21. Schroder, N. W., S. Morath, C. Alexander, L. Hamann, T. Hartung, U. Zahringer, U. B. Gobel, J. R. Weber, and R. R. Schumann. 2003. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278:15587-15594.
22. Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274:17406-17409.
23. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, et al. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive cell wall components. Immunity 11:443-451.
24. Thomas, S., U. Schenk, F. P. Fischer, T. Mettang, J. Passlick-Deetjen, and U. Kuhlmann. 1997. In vitro effects of glucose polymer-containing peritoneal dialysis fluids on phagocytic activity. Am. J. Kidney Dis. 29:246-253.
25. Vink, A., A. H. Schoneveld, J. J. van der Meer, B. J. van Middelaar, J. P. Sluijter, M. B. Smeets, P. H. Quax, S. K. Lim, C. Borst, G. Pasterkamp, and D. P. de Kleijn. 2002. In vivo evidence for a role of Toll-like receptor 4 in the development of intimal lesions. Circulation 106:1985-1990.
26. Wolf, G., J. Bohlender, T. Bondeva, T. Roger, F. Thaiss, and U. O. Wenzel. 2006. Angiotensin II upregulates Toll-like receptor 4 on mesangial cells. J. Am. Soc. Nephrol. 17:1585-1593.
27. Wu, J., X. Yang, Y. F. Zhang, S. F. Zhou, R. Zhang, X. Q. Dong, J. J. Fan, M. Liu, and X. Q. Yu. 2009. Angiotensin II upregulates Toll-like receptor 4 and enhances lipopolysaccharide-induced CD40 expression in rat peritoneal mesothelial cells. Inflamm. Res. 58:473-482.
28. Xu, X. H., P. K. Shah, E. Faure, O. Equils, L. Thomas, M. C. Fishbein, D. Luthringer, X. P. Xu, T. B. Rajavashisth, J. Yano, S. Kaul, and M. Arditi. 2001. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104:3103-3108.
29. Yoshimura, A., E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, and D. T. Golenbock. 1999. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 165:1-5.
30. Yung, S., and T. M. Chan. 2009. Intrinsic cells: mesothelial cells - central players in regulating inflammation and resolution. Perit. Dial. Int. 29(Suppl. 2):S21-S27.
31. Zhang, G., and S. Ghosh. 2001. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J. Clin. Invest. 107:13-19.